Robert Hasserjian
MD
Medicine
Hematology, Pathology
Boston, Massachusetts, United States
Dr. Robert Hasserjian is a Professor of Pathology at Harvard Medical School and a Hematopathologist at Massachusetts General Hospital, where he is the Director of the Hematopathology Fellowship Program. Dr. Hasserjian received his MD from Harvard and trained in Anatomic Pathology and Hematopathology at Brigham and Women's Hospital.? His research interests are in the discovery of pathologic and genetic features associated with the biological behavior of myeloid and lymphoid neoplasms, particularly myelodysplastic syndromes and acute myeloid leukemia.
Dr. Hasserjian is an author of over 200 peer-reviewed publications, reviews, and chapters and is the editor of the textbook “Diagnosis of Blood and Bone Marrow Disorders” (Springer, 2018). He is currently President of the Society for Hematopathology. He is one of the pathology leaders of the 2022 International Consensus Classification of Myeloid Neoplasms and has served as a Senior Reviewer and author of multiple chapters of the revised 4th edition WHO Classification of Myeloid Neoplasms. He was an expert panel member for the 2022 European LeukemiaNet AML Guidelines. Dr. Hasserjian is strongly committed to advancing diagnosis and education in hematopathology and has lectured on the diagnosis of leukemias and other bone marrow disorders at numerous courses and international meetings across the Americas, Europe, and Asia.